MAXIMUS, Inc. (NYSE:MMS) – Research analysts at KeyCorp raised their Q2 2018 earnings estimates for shares of MAXIMUS in a research note issued to investors on Thursday. KeyCorp analyst D. Hooker now forecasts that the health services provider will earn $0.86 per share for the quarter, up from their previous estimate of $0.79. KeyCorp also issued estimates for MAXIMUS’s Q3 2018 earnings at $0.85 EPS and Q4 2018 earnings at $0.82 EPS.

MAXIMUS (NYSE:MMS) last issued its earnings results on Thursday, February 8th. The health services provider reported $0.78 EPS for the quarter, beating the consensus estimate of $0.77 by $0.01. The company had revenue of $623.10 million during the quarter, compared to analysts’ expectations of $624.36 million. MAXIMUS had a net margin of 8.99% and a return on equity of 22.93%. The business’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.71 EPS.

Other analysts have also recently issued research reports about the stock. Zacks Investment Research upgraded shares of MAXIMUS from a “hold” rating to a “buy” rating and set a $71.00 target price for the company in a research report on Tuesday. Maxim Group reiterated a “hold” rating and set a $69.00 target price (up previously from $66.00) on shares of MAXIMUS in a research report on Thursday, February 8th. Finally, Canaccord Genuity reiterated a “buy” rating on shares of MAXIMUS in a research report on Wednesday, December 27th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $66.60.

Shares of MAXIMUS (NYSE MMS) opened at $64.45 on Monday. The company has a market cap of $4,160.60, a price-to-earnings ratio of 19.18, a price-to-earnings-growth ratio of 2.09 and a beta of 1.21. MAXIMUS has a 1 year low of $56.41 and a 1 year high of $72.71. The company has a current ratio of 2.57, a quick ratio of 2.57 and a debt-to-equity ratio of 0.01.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 28th. Investors of record on Thursday, February 15th will be given a $0.045 dividend. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.28%. The ex-dividend date is Wednesday, February 14th. MAXIMUS’s dividend payout ratio is currently 5.36%.

In related news, CEO Richard A. Montoni sold 30,000 shares of the company’s stock in a transaction on Thursday, December 7th. The shares were sold at an average price of $69.25, for a total value of $2,077,500.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Russell A. Beliveau sold 1,000 shares of the company’s stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $71.73, for a total transaction of $71,730.00. The disclosure for this sale can be found here. In the last 90 days, insiders sold 67,517 shares of company stock valued at $4,653,302. 2.48% of the stock is owned by corporate insiders.

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Public Employees Retirement System of Ohio increased its position in shares of MAXIMUS by 42.1% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 104,056 shares of the health services provider’s stock valued at $6,712,000 after buying an additional 30,804 shares in the last quarter. OxFORD Asset Management LLP increased its position in shares of MAXIMUS by 338.0% in the 3rd quarter. OxFORD Asset Management LLP now owns 33,885 shares of the health services provider’s stock valued at $2,186,000 after buying an additional 26,148 shares in the last quarter. Cornerstone Capital Management Holdings LLC. increased its position in shares of MAXIMUS by 798.2% in the 3rd quarter. Cornerstone Capital Management Holdings LLC. now owns 172,286 shares of the health services provider’s stock valued at $11,110,000 after buying an additional 153,104 shares in the last quarter. Jane Street Group LLC bought a new stake in shares of MAXIMUS in the 3rd quarter valued at $359,000. Finally, JPMorgan Chase & Co. increased its position in shares of MAXIMUS by 459.2% in the 2nd quarter. JPMorgan Chase & Co. now owns 25,842 shares of the health services provider’s stock valued at $1,619,000 after buying an additional 21,221 shares in the last quarter. Institutional investors and hedge funds own 95.55% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “MAXIMUS, Inc. to Post Q2 2018 Earnings of $0.86 Per Share, KeyCorp Forecasts (MMS)” was first posted by Daily Political and is owned by of Daily Political. If you are reading this piece on another domain, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The original version of this piece can be read at https://www.dailypolitical.com/2018/02/13/maximus-inc-to-post-q2-2018-earnings-of-0-86-per-share-keycorp-forecasts-mms.html.

About MAXIMUS

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Earnings History and Estimates for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.